Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
Generic name: Letrozole And Ribociclib
Drug class:
Antineoplastic combinations
Usage of Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose are used together in combination to treat HR-positive, HER2-negative breast cancer.
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose is used when the cancer has spread to other parts of the body (metastatic).
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose are two different medicines that are packaged together. Letrozole tablets are yellow and ribociclib tablets are violet.
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may also be used for purposes not listed in this medication guide.
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose side effects
Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may cause serious side effects. Call your doctor at once if you have:
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Common side effects of Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
You should not use this medicine if you are allergic to letrozole (Femara) or ribociclib (Kisqali).
Your doctor will perform medical tests to make sure you do not have conditions that would prevent you from safely using this medicine.
Tell your doctor if you have any signs of infection, such as fever or chills, or if you have ever had:
If you have not gone through menopause, you may need an additional hormonal medication while taking Kisqali Femara Co-Pack 200 mg-2.5 mg Dose. Tell your doctor if you have begun having symptoms of menopause such as irregular menstrual periods, hot flashes, night sweats, sleep problems, or vaginal dryness.
You may need to have a negative pregnancy test before starting this treatment.
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 3 weeks after your last dose. Tell your doctor right away if you become pregnant.
This medicine may affect fertility (ability to have children) in both men and women. However, it is important for women to use birth control to prevent pregnancy because Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may harm the baby if a pregnancy does occur.
You should not breastfeed while using this medicine and for at least 3 weeks after your last dose.
Relate drugs
- Akeega
- Cytarabine and daunorubicin liposomal
- Cedazuridine and decitabine
- Daunorubicin and cytarabine liposome
- Decitabine and cedazuridine
- Inqovi
- Kisqali Femara Co-Pack
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Letrozole and ribociclib
- Lonsurf
- Niraparib and abiraterone
- Nivolumab and relatlimab
- Nivolumab/relatlimab-rmbw
- Opdualag
- Ribociclib and letrozole
- Tipiracil and trifluridine
- Trifluridine and tipiracil
- Vyxeos
- Vyxeos liposomal
How to use Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
It is best to take Kisqali Femara Co-Pack 200 mg-2.5 mg Dose in the morning, but take it at the same time each day. You may take Kisqali Femara Co-Pack 200 mg-2.5 mg Dose with or without food.
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose is given in a 28-day treatment cycle. On days 1 through 21, you will take both ribociclib and letrozole together at the same time each day. During the last 7 days you will take only letrozole each day.
Your doctor may occasionally change the number of tablets in your dose. Follow all dosing instructions very carefully.
Swallow each tablet whole and do not crush, chew, or break it. Do not take any tablet that is broken or cracked.
If you vomit shortly after taking a tablet, do not take another dose. Wait until your next scheduled dose time to take the medicine again.
This medicine can cause a serious heart rhythm or lung problem. Call your doctor at once if you have fast or pounding heartbeats, severe dizziness, or trouble breathing, and shortness of breath.
You will need frequent medical tests while taking Kisqali Femara Co-Pack 200 mg-2.5 mg Dose. Your cancer treatments may be delayed based on the results of these tests.
Do not change your dose or stop taking this medicine without your doctor's advice.
Store each medicine in its original container at room temperature, away from moisture and heat.
Warnings
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose can cause a serious heart rhythm or lung problem. Call your doctor at once if you have fast or pounding heartbeats, severe dizziness, chest pain, or shortness of breath.
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may also affect your liver or blood cells. Tell your doctor if you have right-sided stomach pain, tiredness, flu-symptoms, easy bruising or bleeding, dark urine, or yellowing of the skin or eyes.
This medicine may also cause a severe skin reaction. Get emergency medical help if you have a fever, sore throat, burning eyes, skin pain, or red or purple skin rash with blistering and peeling.
What other drugs will affect Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose can cause a serious heart problem. Your risk may be higher if you also use certain other medicines for infections, asthma, heart problems, high blood pressure, depression, mental illness, cancer, malaria, or HIV.
Many drugs can affect Kisqali Femara Co-Pack 200 mg-2.5 mg Dose. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions